Covalent modifications added to individual nucleotides on mRNAs, called 17 epitranscriptomic modifications, have recently emerged as key regulators of both cellular 18 and viral mRNA function 1,2 and RNA methylation has now been shown to enhance the 19 replication of human immunodeficiency virus 1 (HIV-1) and several other viruses 3-11 . 20 
Introduction 35 Previously, we and others have reported the detection and mapping of several 36 epitranscriptomic modifications on HIV-1 transcripts 3,4,10,15 . These modifications include 37 methylation of the N 6 position of adenosine (m 6 A), of the C 5 position of cytidine (m 5 C) 38 and of the ribose moiety of all four ribonucleotides (2'O-methylation, collectively Nm). All 39 three of these epitranscriptomic modifications have now been shown to boost HIV-1 40 replication in cis. Specifically, m 6 A has been reported to increase viral RNA expression 3,4 , 41 while m 5 C boosts viral mRNA translation 10 and Nm residues increase HIV-1 replication by 42 inhibiting activation of the cellular innate immune factor MDA5 by viral RNAs 15 . While 43 m 6 A, m 5 C and Nm have therefore all been shown to increase HIV-1 gene expression, 44 several other epitranscriptomic mRNA modifications remain unexamined. Of particular 45 interest is the novel mRNA modification ac4C, which was recently reported to enhance 46 cellular mRNA translation and stability 12 and which has previously been reported to 47 represent ~0.5% of all nucleotides (~2% of "C" residues) on the HIV-1 genomic RNA 48 (gRNA), which would equate to ~8 ac4C residues per gRNA 16 . We therefore hypothesized 49 that addition of ac4C residues to HIV-1 transcripts might also serve to boost HIV-1 gene 50 expression and replication. 51 52 53 We have previously used photo-assisted (PA) crosslinking of modification-specific 54 antibodies to 4-thiouridine (4SU)-labelled RNA, followed by RNase footprinting of 55 antibody-bound RNA and deep sequencing of bound RNA fragments, to map both m 6 A 56 (PA-m 6 A-seq) and m 5 C (PA-m 5 C-seq) residues on the gRNAs and mRNAs encoded by 57 4 HIV-1 and other viruses 3,5,6,10 . As an ac4C-specific antibody recently became available, we 58 asked if a similar approach (PA-ac4C-seq) might also allow us to map ac4C modification 59 sites on HIV-1 transcripts 17 . In Fig. 1A , we report the PA-ac4C-seq analysis of HIV-1 60 gRNA, isolated from HIV-1 virions generated in the CEM-SS or SupT1 T cell line, or on 61 intracellular viral RNAs, isolated from CEM-SS cells. Despite some degree of variability 62 in signal intensity, we were able to identify ~11 conserved sites of ac4C addition on HIV-63 1 transcripts that were detected across these three replicates and on additional replicates 64 performed in HIV-1 infected CEM cells ( Fig. S1 ), but not in mock infected cells (Note that 65 the relative weakness of the ac4C sites detected on intracellular RNAs in the gag, pol and 66 env regions is expected as these regions are removed by splicing in many intracellular viral 67 RNAs). Analysis of the location of ac4C sites across the host cell transcriptome confirmed 68 the previous report that the majority of the mapped ac4C residues are located in coding 69 sequences (CDS) 12 , though a substantial number were also located in 3' untranslated 70 regions (UTR) ( Fig. S1B ). Of interest, analysis of all mapped ac4C sites identified a C and 71 U-rich consensus sequence, with a central "UCU" motif, in both uninfected and HIV-1 72 infected CEM cells ( Fig. S1C ). 73
Results & Discussion

74
If the data reported in Fig. 1A indeed map authentic ac4C addition sites, then loss 75 of the "writer" acetyltransferase that deposits these marks should result in the loss of 76 detectable ac4C residues on viral RNAs. Mammals express a single RNA acetyltransferase 77 capable of acetylating RNA, N-acetyltransferase 10 (NAT10), and NAT10 has indeed been 78 reported to add ac4C to mRNAs and non-coding RNAs in human cells 12, 18, 19 . However, 79 NAT10 appears to be essential in human cells and previous efforts to knock down NAT10 80 expression using gene editing by CRISPR/Cas have therefore focused on an exon, exon 5, 81 that is found in the majority of, but not all, mRNAs encoding NAT10 12 . We repeated this 82 strategy in the T cell line CEM and generated 3 clonal cell lines in which all three copies 83 of the NAT10 gene were edited in exon 5 (Figs. S2A, B and C), resulting in a large decrease 84 in NAT10 expression (see below). Of note, these clonal cell lines, referred to as ΔNAT10 85 #3, #7 and #9, did not show any decrease in growth rate ( Fig. S2D ). However, reduced 86 NAT10 expression did result in the expected strong decline in the level of ac4C residues 87 present on viral transcripts as measured by PA-ac4C-seq, thus validating these mapped 88 ac4C sites as authentic ( Fig. 1C ). 89
90
If NAT10 is indeed the writer that deposits ac4C on cellular and viral RNAs, then 91 we reasoned it might be possible to detect NAT10 binding to these sites using the photo-92 assisted cross linking and immunoprecipitation (PAR-CLIP) technique, as previously 93 described 3,20 . We therefore used lentiviral expression vectors encoding FLAG-tagged wild 94 type (WT) NAT10, or FLAG-tagged green fluorescent protein (GFP), to stably express 95 these proteins in CEM cells. As shown in Fig. 1D , we indeed detected FLAG-NAT10, but 96 not FLAG-GFP, binding sites on viral transcripts and these were coincident with the 97 mapped ac4C sites, as expected. Moreover, the mapped NAT10 binding sites conformed 98 to the same U and C-rich sequence consensus, with a central "UCU" motif, that we had 99 identified using PA-ac4C-seq ( Fig. S1C ). 100 101 If ac4C residues indeed facilitate some aspect of HIV-1 gene expression then the 102 reduced expression of NAT10, and concomitant reduction in ac4C addition to mRNAs, 6 seen in the ΔNAT10 CEM cells should result in reduced HIV-1 replication. We analyzed 104 the level of HIV-1 Gag and NAT10 protein expression in WT and ΔNAT10 CEM cells 3 105 days after infection using WT HIV-1 isolate NL4-3. As may be observed in Fig. 2A , both 106 NAT10 and the viral Gag proteins are expressed at a much lower level in the ΔNAT10 107 CEM cells, though the GAPDH loading control was unaffected. Similarly, when we 108 infected WT and ΔNAT10 CEM cells with a previously described replication competent 109
HIV-1 that encodes the Nano luciferase (NLuc) gene in place of the dispensable nef gene 21 , 110
we observed a strong reduction in the level of NLuc protein expression ( Fig it is also possible to inhibit NAT10 function in WT cells using a drug, called Remodelin, 117 that has been reported to inhibit NAT10 function at concentrations that are non-toxic in 118 culture or in mice 13, 14 . Indeed, we observed that Remodelin reduced HIV-1 replication in 119 WT CEM cells by up to 70%, but had little effect on HIV-1 replication in the ΔNAT10 120 CEM cells, at concentrations that did not reduce CEM cell growth ( Fig. 2D ), thus further 121 validating NAT10 as an HIV-1 co-factor. 122 123 As reduced NAT10 expression or function led to diminished HIV-1 replication 124 (Figs. 2A-D), we reasoned that NAT10 activity might be rate limiting for HIV-1 replication 125 in CEM cells. We therefore generated CEM cells stably overexpressing WT NAT10, or 7 mutant forms of NAT10 lacking a functional RNA helicase domain (K290A) or 127 acetyltransferase domain (G641E) ( Fig. 2E ), due to mutagenesis of residues previously 128 shown to be required for RNA acetyltransferase function 14, 19 . All three proteins were 129 expressed at similar levels and at levels that were much higher than endogenous NAT10, 130 as determined by Western blot (Fig. 2G ). Importantly, we detected 4-8x higher levels of 131
HIV-1 replication in the CEM cells overexpressing WT NAT10, but not with either NAT10 132 mutant, when compared to the parental CEM cells and this difference was highly 133 significant ( Fig. 2F ). 134
135
While the data presented in Fig. 2 demonstrate that NAT10, and the ac4C 136 modification, promote some aspect(s) of the HIV-1 replication cycle, they do not identify 137 which step(s) are affected. To address this issue, we performed a single cycle HIV-1 138 replication assay, using WT NL4-3, in WT or ΔNAT10 cells and measured the efficiency 139 of several different steps in the HIV-1 replication cycle. Initially, we measured the level of 140 viral Gag expression, which was found to be reduced by ~70%. Measurement of total viral 141 RNA expression, by qRT-PCR using an LTR-specific probe, also revealed an ~70 % 142 reduction in the ΔNAT10 CEM cells when compared to WT, suggesting an effect primarily 143 at the RNA level ( Fig. 3A) . Indeed, analysis of the level of ribosome binding by viral 144 mRNAs 22 , an assay which had revealed a strong positive effect of the m 5 C modification on 145
HIV-1 mRNA translation 10 , indicated that the presence or absence of ac4C had no 146 discernable effect ( Fig. 3C) . Similarly, reduced ac4C addition did not affect the subcellular 147 location of HIV-1 transcripts ( Fig 3D) , or their alternative splicing ( Fig. S3A ). Importantly, 148 none of the steps from cell entry, reverse transcription to proviral integration were affected 149 by loss of ac4C, as no difference was found in the total level of HIV-1 DNA (Fig. S3B ). 150 However, the reduced expression of NAT10, and the concomitant loss of ac4C on viral 151 transcripts, did result in a highly significant reduction in the stability of HIV-1 transcripts 152 measured either by pulse-chase, using 4SU incorporation into RNA ( Fig. 3E ) 23,24 , or by use 153 of the transcription inhibitor actinomycin D (Fig. S3C ). 154
155
The data presented in Fig 3 argue that, in the case of HIV-1 RNAs, ac4C acts to 156 increase viral gene expression primarily by enhancing viral RNA stability. These data 157 contrast with the previous work proposing that ac4C increases cellular mRNA gene 158 expression by not only increasing mRNA stability but also translation by increasing the 159 CDS decoding efficiency 12 . If this is indeed the primary mechanism of action of ac4C, then 160 only ac4C sites present in the CDS should affect mRNA function in cis. To address this 161 question, we introduced as many silent C to U mutations as possible into conserved ac4C 162 peaks 4 through 8 in the viral env gene region ( Fig. 4A and Figs. S4A and B). We then 163 transfected WT 293T cells, which lack CD4 and therefore will not support a spreading 164 infection, and measured HIV-1 Gag protein expression. As shown in Figs. 4B and 4C, the 165 ac4C site mutations introduced into the env gene, which would be present exclusively in 166 the 3' UTR of the viral gag mRNA ( Fig. 1B) , nevertheless reduced Gag protein expression 167 in cis, both in the producer cells ( Fig. 4B ) and in the supernatant media (Fig. 4C ). The 168 observed reduction of ~60% was not only highly significant but also only slightly less than 169 seen in the ΔNAT10 CEM cells (Fig. 3A) . 170 171 It could be argued that the inhibition of Gag expression seen with the env gene ac4C 172 mutant (Figs 4B and C) was not due to loss of ac4C residues but rather due to disruption 173 of some other sequence element that is functionally significant. To test this idea, we 174 collected the WT and mutant virions released by the transfected 293T cells, normalized the 175 p24 level based on Fig. 4C and then infected WT and ΔNAT10 CEM cells. We then 176 measured the level of Gag expression after a single round of replication in these cells by 177
Western. A representative experiment is shown in Fig. 4D , while a compilation of data 178 measuring total Gag protein expression ( Fig. 4E ) or exclusively p24 Gag expression (Fig. 179 4G) are also presented. We noted a bigger effect on p24 Gag expression than on total Gag 180 protein expression and therefore present both data sets. As may be observed, the env ac4C 181 site mutations reduced total Gag protein expression by 2.3x, and p24 Gag expression by 182 4.0x, in the WT CEM cells. In contrast, these same mutations reduced total Gag protein 183 expression by 1.7x, and p24 expression by 2.1x, in the ΔNAT10 CEM cells, and these 184 differences are statistically significant. Therefore, these data demonstrate that the 185 mutagenesis of mapped env ac4C sites indeed results a stronger inhibitory phenotype in 186 CEM cells expressing WT levels of NAT10 than in the ΔNAT10 CEM cells that express 187 reduced levels of NAT10, as would be predicted if they indeed act via the same mechanism. 188 189 Previously, several groups have reported that the epitranscriptomic addition of m 6 A 190 to viral transcripts can significantly enhance the replication of a range of different viruses, 191
including HIV-1, influenza A virus, SV40, enterovirus 71, respiratory syncytial virus and 192
Kaposi's sarcoma-associated herpesvirus 3-9,11 . Less is known about other epitranscriptomic 193 viral RNA modifications, though both m 5 C and Nm residues have been detected on HIV-1 194 transcripts at levels that are substantially higher than seen on cellular mRNAs and both 195 m 5 C and Nm have been reported to enhance HIV-1 replication in culture 10, 15 . Interestingly, 196 the proposed mechanisms used by these distinct epitranscriptomic modifications appear 197 distinct in that m 6 A has been proposed to increase viral mRNA expression levels 3,4 while 198 m 5 C acts primarily by boosting viral mRNA translation 10 . Finally Nm has been reported to 199 increase HIV-1 replication indirectly by preventing the activation of the host innate 200 immune factor MDA5 by viral transcripts 15 . Here, we extend this previous work by looking 201 at a novel epitranscriptomic modification, ac4C, that has been proposed to boost cellular 202 mRNA translation and stability 12 and that has also been detected on purified HIV-1 203 genomic RNA 16 . We have mapped the ac4C residues present on HIV-1 RNAs to ~11 204 distinct sites and show that these are, as expected, deposited by the host acetyltransferase 205 NAT10, as inhibition of NAT10 expression results in a loss of ac4C from viral RNAs 206 ( Fig.1) . Importantly, the loss of ac4C modifications from viral transcripts results in reduced 207 viral gene expression and replication whether caused by a reduction in NAT10 expression 208 due to gene editing ( Figs. 2A and B and Fig. 3 ), inhibition of NAT10 function using the 209 drug Remodelin (Fig. 2D ) or by mutagenesis of mapped ac4C sites (Fig. 4 ). However, in 210 the case of HIV-1 transcripts, the positive effect of ac4C modifications appears to be due 211 entirely to stabilization of viral transcripts (Figs. 3E and S3C) . In contrast, Arango et al. 12 212 reported that ac4C residues in cellular CDS not only increased mRNA stability but also 213 increased mRNA translation, by increasing decoding efficiency. We did not observe any 214 increase in ribosome recruitment to HIV-1 mRNAs (Fig. 3C) into the NotI and EcoRI sites of pK-FLAG-VP1 6 , placing NAT10 3' to a 2xFLAG tag and 330 replacing SV40 VP1. The NAT10 cDNA sequence was confirmed as wild type by Sanger 331 DNA sequencing. The K290A & G641E point mutants were introduced by recombinant 332 PCR: two complementing PCR primers were designed to overlap the mutated region, with 333 the point mutant sequence in the middle. A first round of PCR was done to separately 334 amplify the 5'end-to-mutation site and the mutation site-to-3'end fragments of NAT10, 335 yielding two fragments with a region of homology around the mutation site. Using two 336 outer primers, the two fragments were joined and amplified into the full length NAT10 337 CDS containing the point mutation and then ligated into the NotI and EcoRI sites of pK-338 FLAG as before. The lentiviral expression construct pLEX-FLAG-NAT10 was constructed 339 by cloning the PCR amplified FLAG-NAT10 cDNA from pK-FLAG-NAT10 into the 340 BamHI and AgeI sites of the pLEX vector (Openbiosystems). All PCR primers used are 341 listed in Supplemental Table 1 . 342 343
Viral infection of 293T cells 344
293T cells seeded in 6 well plates were transfected using PEI with 1.6 µg of pK-345 FLAG-NAT10 plasmids or empty pK vector, along with 250 ng of CD4 expression 346 vector 36 , and 100 ng of firefly luciferase (FLuc) expression plasmid pcDNA3-FLuc. In 347 parallel, 10µg of pNL43-NLuc was transfected into 293T cells in 10 cm plates. All media 348 were changed the next day, and the NAT10/CD4/FLuc+ infected target cells split into 12 349 well plates two days later. NL43-NLuc virus-containing supernatant was harvested on day Power SYBR Green Master Mix (ABI), with primers targeting either the U3 region of HIV-381 1 LTR or spanning splice donor 1 and splice acceptor 1 (D1-A1). qPCR readouts were 382 normalized to GAPDH levels using the delta-delta Ct (ddCt) method. All PCR primers 383 used are listed in Supplemental Table 1 . Sub-cellular fractionation and ribosome 384 association assays were done on single-round infected cells, as previously described for 385 fractionation 6,37 and ribosome association 10,22 . HIV-1 RNA splicing was assayed by 386
Primer-ID tagged deep sequencing 10,38 . HIV-1 Gag protein expression levels were 387 analyzed by Western blot. Western blot band intensity was quantified using Image J 388 software. Released viral particles were quantified using an HIV-1 p24 antigen capture 389 ELISA assay (Advanced Bioscience Laboratories #5421). 390
391
RNA decay assays 392
The nascent RNA isolation method used is a combination of two protocols 23, 24 . 393
Single-round-infected cells were pulsed at 48 hpi with 150 µM 4SU for 1.5 hours, the cells 394 then washed and resuspended in 4SU-free fresh RPMI. Cells were collected at 0, 2, and 4 395 h after 4SU wash out and RNA extracted using Trizol. 500 ng of MTSEA-biotin-XX 396 (Biotium 89139-636) dissolved in 10 µl of Dimethyl formamide (Sigma D4551) was used 397 to biotinylate 6 µg of RNA in a 50 µl reaction mixture with 20mM HEPES pH7.4 and 1mM 398 EDTA at room temperature for 30 min. Excess biotin was removed by two rounds of 399 chloroform extraction followed by isopropanol precipitation of RNA. 100 µg of 400 streptavidin magnetic beads (NEB, S1420S) were pre-blocked with glycogen, then co- The gag protein bands (p55+p24) from 6 repeats of panel D were quantified and the 600
